NA Heart Valve Repair and Replacement Market- Industry Trends and Forecast to 2035

NA Heart Valve Repair and Replacement Market- Industry Trends and Forecast to 2035

The North America heart valve repair and replacement market is expected to reach USD 11,585.65 million by 2031 from 5,485.39 million in 2024, growing with a substantial CAGR of 11.3% in the forecast period of 2024 to 2031.

Market Segmentation:
North America Heart Valve Repair And Replacement Market, By Product (Surgical Heart Valve Replacement, Surgical Heart Valve Repair, Tavi / Tavr Valves, Grafts, Patches, Medication, and Others), Procedure (Surgical Procedure and Non-Surgical Procedure), Indication (Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse, and Others), End User (Hospital, Specialty Centers, Cardiac Catheterization Lab, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of North America Heart Valve Repair And Replacement Market Dynamics

Driver
• Rise in incidence of valvular heart defects
Restraint

• High cost associated with cardiovascular disease treatment

Opportunity

• Rise in demand for minimally invasive technology

Market Players

Some of the key players operating in the North America heart valve repair and replacement market are:
• MVRx, Inc.
• MeKo Laser Material Processing
• Comed B.V.
• CardiaMed
• Xeltis
• Foldax, Inc.
• JenaValve Technology, Inc.
• Colibri Heart Valve
• HLT, Inc.
• NeoChord, Inc.
• Meril Life Sciences Pvt. Ltd.
• Micro Interventional Devices, Inc.
• Biotronik
• Medtronic
• Abbott
• Neovasc Inc.
• Edwards Lifesciences Corporation



Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.